george.granda@uprisehealth.com

Shortening the Current Opioid Misuse Measure via computer-based testing: a retrospective proof-of-concept study

Authors: Finkelman, M. D.; Kulich, R. J.; Zoukhri, D.; Smits, N.;…

Learn More

Collaboration or Coercion? Partnering to Divert Prescription Opioid Medications

Authors: Green, T. C.; Bowman, S. E.; Ray, M.; Zaller, N.,…

Learn More

Spanish Translation and Linguistic Validation of the Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP-R)

Authors: Butler, S. F.; Zacharoff, K. L.; Budman, S. H.; Jamison,…

Learn More

The Feasibility of Pharmacy-Based Naloxone Distribution Interventions: A Qualitative Study With Injection Drug Users and Pharmacy Staff in Rhode Island

Authors: Zaller, N.; Yokell, M. A.; Green, T. C. Substance Use…

Learn More

Abuse of Reformulated OPANA® ER: early findings from NAVIPPRO® data

Theresa A. Cassidy, MPH, Emily C. McNaughton, MPH , Kimberly…

Learn More

How does use of a prescription monitoring program change pharmacy practice?

Based on a recent study, our team has published an…

Learn More